APA (7th ed.) Citation

Willemse, E. A., Sandgren, S., Benkert, P., Schaedelin, S., Maceski, A. M., Oechtering, J., . . . Hoepner, R. (2026). Serum GFAP as a biomarker for progression in multiple sclerosis: Assay comparison and a large reference database of healthy controls. Clinical Chemistry & Laboratory Medicine, 64(5), 1046. https://doi.org/10.1515/cclm-2025-1480

Chicago Style (17th ed.) Citation

Willemse, Eline A.J., et al. "Serum GFAP as a Biomarker for Progression in Multiple Sclerosis: Assay Comparison and a Large Reference Database of Healthy Controls." Clinical Chemistry & Laboratory Medicine 64, no. 5 (2026): 1046. https://doi.org/10.1515/cclm-2025-1480.

MLA (9th ed.) Citation

Willemse, Eline A.J., et al. "Serum GFAP as a Biomarker for Progression in Multiple Sclerosis: Assay Comparison and a Large Reference Database of Healthy Controls." Clinical Chemistry & Laboratory Medicine, vol. 64, no. 5, 2026, p. 1046, https://doi.org/10.1515/cclm-2025-1480.